ESO - RUSSCO Session on Immune Checkpoint Blockage in Cancer Therapy
Not eligible for ESCO credits
18.11.2015
COURSES AND SEMINARS
Description
Faculty list
FACULTY
E. Artamonova, RU
V. Breder, RU
G. Curigliano, IT
M. Maio, IT
D. Nosov, RU
R. Rosell, ES
Programme
18 November
14:10 | The evolving role of immune checkpoint inhibitors in cancer treatment | |
14:30 | Questions | |
14:35 | Biological markers of response to immune checkpoint inhibitors R. Rosell, ES | |
14:55 | Questions | |
15:00 | Non-small cell lung cancer (NSCLC): changing landscape of treatment and current issues V. Breder, RU | |
15:20 | Questions | |
15:25 | Immune checkpoint Inhibitors for urologic cancer (RCC and bladder cancer) D. Nosov, RU | |
15:45 | Questions | |
15:50 | Immune checkpoint-blockage induced toxicity G. Curigliano, IT | |
16:10 | Questions | |
16:15 | Checkpoint inhibitors: rational for combination strategy (vaccines, antiangiogenesis) M. Maio, IT | |
16:35 | Questions | |